Mizuho Maintains Neutral on Doximity, Lowers Price Target to $26
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
Mizuho analyst Steven Valiquette maintains Doximity (NYSE:
DOCS) with a Neutral and lowers the price target from $34 to $26.
